stiftungslehrstuhle neurowissenschaften

Reference: Prof. Dr. Oliver Brustle Abstract: PROJECT DETAILS  beginning: 2012. end: 2013. Country of research: Germany Counry of funding source: Germany Funding organization: Hertie Foundation Financing: PRIVATE FUNDERS – 246 000 € hyperlink

Family outcomes

Reference: Danijela Vlajic Abstract: The European Project for Rare Diseases National Plans Development (EUROPLAN) has addressed one unanswered question to date: モwhat is the scope of patient-driven research?ヤ Identification of needs and priorities for translational and social research, modes of fostering them and promotion of interdisciplinary cooperative approaches has been largely recommended. Beside the success … Read more

E patient

Reference: Thomas Bertrand1 Abstract: Health is today the number 1 use of Internet. E patients are health consumers who use the internet to gather, share, produce information about a medical condition of particular interest to them. Health social networks are becoming an important entity of influence in the medicine of the future, as they are … Read more

Immunomodulatory role of MeCP2 and Rett syndrome.

Reference: Miralv?s Julie Abstract: Rett syndrome is a severe progressive neurodevelopmental disorder caused by dominant mutations in the MECP2 gene. The MeCP2 protein, highly expressed in mature neurons, is a transcriptional repressor of the family of Methyl-CpG-binding proteins (MBP) characterized by their ability to bind to methylated CpG nucleotides. Although the molecular mechanisms responsible for … Read more

G?ne ARX et retard mental

Reference: Jamel CHELLY ヨ CHU Cochin ? Paris Abstract: n.a PROJECT DETAILS  beginning: 2002. end: 2002. Country of research: France Counry of funding source: France Funding organization: FFRE fondation-epilepsie Financing: PRIVATE FUNDERS – 15 000 € hyperlink

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close